BRCA2 and cancer: We here show that combining homozygous hypomorphic Brca2/Fancd1 and Rad51c/Fanco mutations in mice by polygenic crosses recapitulates a wide spectrum of the human FA disease, including congenital anomalies, hematopoietic malfunction, and cancer at a young age.